PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

PCI Pharma Services Expands Biologics Leadership with new Center of Excellence Facility in the Midwest

New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies P...
Continue Reading →
News

Richard Stedman rejoins ACG as the CEO of Engineering Division

ACG, a leading supplier of integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, is pleased to announce that Richard Stedman ...
Continue Reading →
News

Noema Pharma raises crucial financing for treatments

The company has raised $112m in order to develop therapies for central nervous system disorders. Noema Pharma – a company targeting debilitating central nervous s...
Continue Reading →
News

Protalix and Chiesi gain positive opinion for pegunigalsidase alfa

The therapy becomes the first pegylated enzyme for the treatment of adult patients with Fabry disease. Chiesi Global Rare Diseases – part of the Chiesi Group – an...
Continue Reading →
News

Moderna opts for Oxfordshire in a quest for innovation

Vaccines developed at the facility will cover a wide range of respiratory diseases. Moderna has revealed that Harwell – the notable science and innovation campus ...
Continue Reading →
News

Sequana Medical announces positive results for DSR 2.0 candidate

An extensive phase 1 clinical trial evaluates the safety of treatment among peritoneal patients. Sequana Medical – a company focused on treating fluid overload in...
Continue Reading →
News

Amniotics’ PulmoStem receives positive safety data

Treatment is a lung-specific stem cell therapy designed for hospitalised patients with respiratory infections. Amniotics AB has announced that safety criteria hav...
Continue Reading →
News

Catch Up with PHARMAP 2023:Pharmaceutical Challenges and Strategies

Design and optimization of the supply chain, packaging solutions for security and brand protection, cost-effective technologies towards continuous manufacturing, and...
Continue Reading →
News

Hope for Parkinson’s disease and Lewy body dementia patients

Research into modified RNA messages could help treat diseases and develop new therapies. Toxic proteins within the brain that cause Parkinson’s disease and Lewy b...
Continue Reading →
News

OKYO Pharma reveals update on dry eye disease candidate

Phase 2 study of OK-101 will commence soon as the company hopes the drug will provide an unmet need. OKYO Pharma – a company focused on drug development in ophtha...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026